These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15541909)

  • 21. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
    Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
    AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films.
    Kramar A; Turk S; Vrecer F
    Int J Pharm; 2003 Apr; 256(1-2):43-52. PubMed ID: 12695010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactic acid-induced modifications in films of Eudragit RL and RS aqueous dispersions.
    Omari DM; Sallam A; Abd-Elbary A; El-Samaligy M
    Int J Pharm; 2004 Apr; 274(1-2):85-96. PubMed ID: 15072785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.
    El-Malah Y; Nazzal S
    Int J Pharm; 2008 Jun; 357(1-2):219-27. PubMed ID: 18353571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
    Devrim B; Canefe K
    Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity of cationic polymer Eudragit RL to electrolytes and its effect on drug release from Eudragit RL matrix].
    Fu C; Zhao L; Jiang X
    Yao Xue Xue Bao; 1998 Jul; 33(7):538-43. PubMed ID: 12016889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of surfactants in aqueous-based polymeric dispersions on the thermomechanical and adhesive properties of acrylic films.
    Felton LA; Austin-Forbes T; Moore TA
    Drug Dev Ind Pharm; 2000 Feb; 26(2):205-10. PubMed ID: 10697758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of poly(meth)acrylates for the control and release of pholedrine sulfate from microdragees].
    Hennig D; Kala H
    Pharmazie; 1985 Aug; 40(8):554-7. PubMed ID: 4080801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
    Sungthongjeen S; Paeratakul O; Limmatvapirat S; Puttipipatkhachorn S
    Int J Pharm; 2006 Nov; 324(2):136-43. PubMed ID: 16828997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of dry coated solid dosage forms.
    Kablitz CD; Urbanetz NA
    Pharm Dev Technol; 2009; 14(6):613-22. PubMed ID: 19883250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery.
    Semdé R; Amighi K; Devleeschouwer MJ; Moës AJ
    Int J Pharm; 2000 Mar; 197(1-2):181-92. PubMed ID: 10704805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug release modification by interpolymer interaction between countercharged types of Eudragit® RL 30D and FS 30D in double-layer films.
    Moustafine RI; Bodrov AV; Kemenova VA; Rombaut P; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):17-21. PubMed ID: 23041129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
    Lin AY; Muhammad NA; Pope D; Augsburger LL
    AAPS PharmSci; 2001; 3(2):E14. PubMed ID: 11741265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs acting as plasticizers in polymeric systems: a quantitative treatment.
    Siepmann F; Le Brun V; Siepmann J
    J Control Release; 2006 Oct; 115(3):298-306. PubMed ID: 17045358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
    Lunio R; Sawicki W
    Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.